Affiliations: Dana-Farber/Harvard Cancer Center and Brigham and Women’s Hospital, Boston, MA

Areas of specialization: pathology, benign breast disease, breast cancer

Dr. Schnitt is the chief of breast oncologic pathology for the Dana-Farber Brigham Cancer Center, associate director of the Dana-Farber Cancer Institute/Brigham and Women’s Hospital Breast Oncology Program, co-leader of the Dana-Farber Harvard Cancer Center Breast Program, senior pathologist at Brigham and Women’s Hospital, professor of pathology at Harvard Medical School and an internationally recognized expert in breast pathology. He has published more than 340 original articles, review articles, editorials, commentaries, and book chapters, primarily in the area of breast diseases. He has authored a popular breast pathology textbook, Biopsy Interpretation of the Breast, now its third edition. His research interests focus on risk factors for local recurrence in patients with invasive breast cancer and ductal carcinoma in situ (DCIS) treated with lumpectomy, benign breast disease and breast cancer risk, and stromal-epithelial interactions in breast tumor progression.